| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q4 2014 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Vanguard Dividend Appreciation ETF | 24 | Q3 2023 | 13.4% |
| iShares S&P 500 Value ETF | 24 | Q3 2023 | 10.4% |
| Microsoft Corp | 24 | Q3 2023 | 2.7% |
| Oracle Corp | 24 | Q3 2023 | 1.7% |
| Vanguard S&P 500 ETF | 24 | Q3 2023 | 1.9% |
| Novo Nordisk A/S Spons Adr | 24 | Q3 2023 | 1.4% |
| Vanguard S&P 500 Value ETF | 24 | Q3 2023 | 3.9% |
| Johnson & Johnson | 24 | Q3 2023 | 1.2% |
| Nike Inc Cl B | 24 | Q3 2023 | 1.2% |
| SPDR S&P 500 ETF | 24 | Q3 2023 | 1.2% |
View Arlington Partners LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-16 |
| 13F-HR | 2024-01-24 |
| 13F-HR | 2023-10-24 |
| 13F-HR | 2023-07-26 |
| 13F-HR | 2023-04-26 |
| 13F-HR/A | 2023-01-24 |
| 13F-HR | 2023-01-19 |
| 13F-HR | 2022-10-28 |
| 13F-HR | 2022-07-25 |
| 13F-HR | 2022-04-14 |
View Arlington Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.